Fig. 5From: Effects of recombinant human growth hormone treatment on growth, body composition, and safety in infants or toddlers with Prader-Willi syndrome: a randomized, active-controlled triala Mean change in bone mineral density at week 52 from baseline b Mean change in bone age at week 52 from baseline. P-value was obtained from Paired t-test. CI, confidence interval; SE, standard errorBack to article page